Furthermore, the IGF1 neutralization antibody significantly reduced tumor number in both the antibody-alone group (10 per mouse) and the GSK-J4 combination group (3.5 per mouse) (Figs. 5F and S5E). This evidence concerns the gene IGF1 and neoplasm.